Trial in progress (XALute): Phase 3 study of xaluritamig vs investigator’s choice of cabazitaxel or second androgen receptor directed therapy (ARDT) in post-taxane metastatic castration-resistant ...

SHR-A1811 in HER2-expressing salivary gland cancers: Preliminary efficacy and safety results. Neoadjuvant pembrolizumab in combination with dabrafenib and trametinib (DTP) for BRAF V600E-mutated ...

Scientists are aiming to determine the composition and topology of physiological Ashwell-Morell receptor ligands. Their findings will help uncover the receptor's still-hidden secrets. After ...

Recent breakthroughs in understanding the prostaglandin D2 (PGD 2) receptor 1 (DP1) are paving the way for innovative anti-inflammatory and immunomodulatory therapies. DP1, a G protein-coupled ...

Just like using Vaseline to prevent nail polish from staining skin, Newsom aims to shield California from the detrimental effects of climate change. However, while Vaseline can temporarily fix ...

Changes in skin color can occur for many reasons. The skin may appear temporarily blotchy due to being hot or blushing. In other cases, discoloration can signal a health condition. Several factors ...

One factor is that the genetic makeup of prostate cancer cells can change over time, allowing them to produce more androgen receptors (binding sites for testosterone). Remarkably, prostate cancer ...

Dr. David Morris presented results from the TRITON3 study of rucaparib versus docetaxel or a second-generation androgen receptor pathway inhibitor (ARPI) in metastatic castrate-resistant prostate ...

Dr. Manish Patel presented the results of an exploratory analysis evaluating BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, for heavily pre-treated patients ...